Literature DB >> 5838330

Cytologic dysplasia occurring after busulfan (Myleran) therapy. A syndrome resembling adrenocortical insufficiency and atrophic bronchitis.

H N Ward, N Konikov, E H Reinhard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 5838330     DOI: 10.7326/0003-4819-63-4-654

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  3 in total

1.  Lung function in patients receiving busulphan.

Authors:  W A Littler; C Ogilvie
Journal:  Br Med J       Date:  1970-11-28

2.  Busulphan lung.

Authors:  B E Heard; R A Cooke
Journal:  Thorax       Date:  1968-03       Impact factor: 9.139

3.  Endocrine sequelae of cancer and cancer treatments.

Authors:  Charles J Stava; Camilo Jimenez; Rena Vassilopoulou-Sellin
Journal:  J Cancer Surviv       Date:  2007-11-20       Impact factor: 4.442

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.